Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 3
2013 1
2014 1
2015 3
2017 4
2018 1
2019 2
2020 1
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Laboratory biomarkers in Alzheimer's disease.
Steinerman JR, Honig LS. Steinerman JR, et al. Curr Neurol Neurosci Rep. 2007 Sep;7(5):381-7. doi: 10.1007/s11910-007-0059-6. Curr Neurol Neurosci Rep. 2007. PMID: 17764627 Review.
A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.
Giovannoni G, Knappertz V, Steinerman JR, Tansy AP, Li T, Krieger S, Uccelli A, Uitdehaag BMJ, Montalban X, Hartung HP, Pia Sormani M, Cree BAC, Lublin F, Barkhof F. Giovannoni G, et al. Among authors: steinerman jr. Neurology. 2020 Aug 25;95(8):e1027-e1040. doi: 10.1212/WNL.0000000000010284. Epub 2020 Jul 10. Neurology. 2020. PMID: 32651286 Clinical Trial.
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
Comi G, Dadon Y, Sasson N, Steinerman JR, Knappertz V, Vollmer TL, Boyko A, Vermersch P, Ziemssen T, Montalban X, Lublin FD, Rocca MA, Volkinshtein R, Rubinchick S, Halevy N, Filippi M. Comi G, et al. Among authors: steinerman jr. Mult Scler. 2022 Apr;28(4):608-619. doi: 10.1177/13524585211032803. Epub 2021 Aug 11. Mult Scler. 2022. PMID: 34378456 Clinical Trial.
20 results